BioSpace News Archive

Press Releases

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

March 2, 2026
·
7 min read
Press Releases

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

March 2, 2026
·
9 min read
Press Releases

Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa

March 2, 2026
·
7 min read
Press Releases

GT Biopharma Reports Full Year 2025 Financial Results

March 2, 2026
·
8 min read
Press Releases

NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer

March 2, 2026
·
6 min read
Press Releases

EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema

March 2, 2026
·
12 min read
Press Releases

Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results

March 2, 2026
·
10 min read
Press Releases

Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

March 2, 2026
·
9 min read
Press Releases

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

March 2, 2026
·
5 min read
Press Releases

Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

March 2, 2026
·
3 min read